CN110551672B - 高产反式-4-羟基-l-脯氨酸的大肠杆菌菌株及其构建方法 - Google Patents
高产反式-4-羟基-l-脯氨酸的大肠杆菌菌株及其构建方法 Download PDFInfo
- Publication number
- CN110551672B CN110551672B CN201910940707.3A CN201910940707A CN110551672B CN 110551672 B CN110551672 B CN 110551672B CN 201910940707 A CN201910940707 A CN 201910940707A CN 110551672 B CN110551672 B CN 110551672B
- Authority
- CN
- China
- Prior art keywords
- gene
- proline
- utr
- escherichia coli
- promoter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 title claims abstract description 50
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 title claims abstract description 32
- PMMYEEVYMWASQN-IMJSIDKUSA-N trans-4-Hydroxy-L-proline Natural products O[C@@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-IMJSIDKUSA-N 0.000 title claims abstract description 32
- 238000010276 construction Methods 0.000 title claims abstract description 22
- 241000894006 Bacteria Species 0.000 claims abstract description 89
- 108020003589 5' Untranslated Regions Proteins 0.000 claims abstract description 71
- 241000588724 Escherichia coli Species 0.000 claims abstract description 60
- 101150046501 proB gene Proteins 0.000 claims abstract description 50
- 238000000034 method Methods 0.000 claims abstract description 44
- 108700023479 Glutamate 5-kinases Proteins 0.000 claims abstract description 42
- 101150108812 proC gene Proteins 0.000 claims abstract description 42
- 102000005133 Glutamate 5-kinase Human genes 0.000 claims abstract description 38
- 101100189062 Bacillus subtilis (strain 168) proH gene Proteins 0.000 claims abstract description 35
- 101150108780 pta gene Proteins 0.000 claims abstract description 16
- 101150094017 aceA gene Proteins 0.000 claims abstract description 15
- 101150014383 adhE gene Proteins 0.000 claims abstract description 14
- 101150038927 pdhR gene Proteins 0.000 claims abstract description 14
- 101150060030 poxB gene Proteins 0.000 claims abstract description 14
- 101150041530 ldha gene Proteins 0.000 claims abstract description 13
- 101150068263 putA gene Proteins 0.000 claims abstract description 13
- 230000035772 mutation Effects 0.000 claims abstract description 11
- 108030002926 L-proline trans-4-hydroxylases Proteins 0.000 claims abstract description 10
- 101150111581 pflB gene Proteins 0.000 claims abstract description 8
- 101150118781 icd gene Proteins 0.000 claims description 48
- 101150099894 GDHA gene Proteins 0.000 claims description 46
- 101150106096 gltA gene Proteins 0.000 claims description 39
- 101150118057 proA gene Proteins 0.000 claims description 37
- 108090000623 proteins and genes Proteins 0.000 claims description 32
- 101150053555 acnB gene Proteins 0.000 claims description 30
- 101100245038 Synechocystis sp. (strain PCC 6803 / Kazusa) proA1 gene Proteins 0.000 claims description 28
- 101150001446 aceK gene Proteins 0.000 claims description 15
- 108020004705 Codon Proteins 0.000 claims description 12
- 108091026898 Leader sequence (mRNA) Proteins 0.000 claims description 9
- 101100242035 Bacillus subtilis (strain 168) pdhA gene Proteins 0.000 claims description 8
- 101100123255 Komagataeibacter xylinus aceC gene Proteins 0.000 claims description 8
- 101100134871 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) aceE gene Proteins 0.000 claims description 8
- 101150070136 axeA gene Proteins 0.000 claims description 8
- 239000004475 Arginine Substances 0.000 claims description 5
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 5
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 claims description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 4
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract description 22
- 229960002429 proline Drugs 0.000 abstract description 21
- 229930182821 L-proline Natural products 0.000 abstract description 17
- 230000004151 fermentation Effects 0.000 abstract description 12
- 238000000855 fermentation Methods 0.000 abstract description 12
- 239000002994 raw material Substances 0.000 abstract description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 4
- 239000008103 glucose Substances 0.000 abstract description 4
- 239000000758 substrate Substances 0.000 abstract description 3
- 238000010353 genetic engineering Methods 0.000 abstract description 2
- 239000013612 plasmid Substances 0.000 description 110
- 239000012634 fragment Substances 0.000 description 85
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 71
- 229930027917 kanamycin Natural products 0.000 description 70
- 229960000318 kanamycin Drugs 0.000 description 70
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 70
- 229930182823 kanamycin A Natural products 0.000 description 70
- 101150072344 argA gene Proteins 0.000 description 38
- 229960000268 spectinomycin Drugs 0.000 description 33
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 33
- 238000012408 PCR amplification Methods 0.000 description 32
- 101150042350 gltA2 gene Proteins 0.000 description 29
- 101100277701 Halobacterium salinarum gdhX gene Proteins 0.000 description 25
- 101100392454 Picrophilus torridus (strain ATCC 700027 / DSM 9790 / JCM 10055 / NBRC 100828) gdh2 gene Proteins 0.000 description 25
- 101100116769 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) gdhA-2 gene Proteins 0.000 description 25
- 235000011187 glycerol Nutrition 0.000 description 24
- 239000002609 medium Substances 0.000 description 22
- 230000003321 amplification Effects 0.000 description 21
- 238000003199 nucleic acid amplification method Methods 0.000 description 21
- 230000001580 bacterial effect Effects 0.000 description 20
- 101100378193 Dictyostelium discoideum aco2 gene Proteins 0.000 description 19
- 239000007788 liquid Substances 0.000 description 19
- 108020004414 DNA Proteins 0.000 description 18
- 108091033409 CRISPR Proteins 0.000 description 16
- 108091028043 Nucleic acid sequence Proteins 0.000 description 16
- 239000000203 mixture Substances 0.000 description 16
- 239000011248 coating agent Substances 0.000 description 15
- 238000000576 coating method Methods 0.000 description 15
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 13
- 230000015572 biosynthetic process Effects 0.000 description 13
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 13
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 12
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 12
- 230000000295 complement effect Effects 0.000 description 12
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 11
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 11
- 101150038500 cas9 gene Proteins 0.000 description 11
- 239000001963 growth medium Substances 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- GQPLMRYTRLFLPF-UHFFFAOYSA-N nitrous oxide Inorganic materials [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 10
- 239000013598 vector Substances 0.000 description 10
- KPGXRSRHYNQIFN-UHFFFAOYSA-L 2-oxoglutarate(2-) Chemical compound [O-]C(=O)CCC(=O)C([O-])=O KPGXRSRHYNQIFN-UHFFFAOYSA-L 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 238000003209 gene knockout Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 230000004913 activation Effects 0.000 description 7
- 229960000723 ampicillin Drugs 0.000 description 7
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 7
- 108010008221 formate C-acetyltransferase Proteins 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 6
- 101100462488 Phlebiopsis gigantea p2ox gene Proteins 0.000 description 6
- 101100398785 Streptococcus agalactiae serotype V (strain ATCC BAA-611 / 2603 V/R) ldhD gene Proteins 0.000 description 6
- 101100386830 Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4) ddh gene Proteins 0.000 description 6
- 230000003213 activating effect Effects 0.000 description 6
- 101150026107 ldh1 gene Proteins 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 241000660147 Escherichia coli str. K-12 substr. MG1655 Species 0.000 description 5
- 229940041514 candida albicans extract Drugs 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000010362 genome editing Methods 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 239000012137 tryptone Substances 0.000 description 5
- 239000012138 yeast extract Substances 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 101100277697 Bacillus subtilis (strain 168) rocG gene Proteins 0.000 description 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- SCJNCDSAIRBRIA-DOFZRALJSA-N arachidonyl-2'-chloroethylamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCCl SCJNCDSAIRBRIA-DOFZRALJSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 4
- 238000005457 optimization Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- 101100397224 Bacillus subtilis (strain 168) isp gene Proteins 0.000 description 3
- 238000010354 CRISPR gene editing Methods 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- 102000004079 Prolyl Hydroxylases Human genes 0.000 description 3
- 108010043005 Prolyl Hydroxylases Proteins 0.000 description 3
- 101100052502 Shigella flexneri yciB gene Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 229930195712 glutamate Natural products 0.000 description 3
- 230000034659 glycolysis Effects 0.000 description 3
- 101150064873 ispA gene Proteins 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 241000186226 Corynebacterium glutamicum Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 229940100228 acetyl coenzyme a Drugs 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 108010015942 isocitrate dehydrogenase kinase Proteins 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- ODBLHEXUDAPZAU-UHFFFAOYSA-N threo-D-isocitric acid Natural products OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 2
- 108010030844 2-methylcitrate synthase Proteins 0.000 description 1
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 description 1
- 101800001241 Acetylglutamate kinase Proteins 0.000 description 1
- 102000009836 Aconitate hydratase Human genes 0.000 description 1
- 108010009924 Aconitate hydratase Proteins 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 108010032178 Amino-acid N-acetyltransferase Proteins 0.000 description 1
- 102000007610 Amino-acid N-acetyltransferase Human genes 0.000 description 1
- 108010071536 Citrate (Si)-synthase Proteins 0.000 description 1
- 102000006732 Citrate synthase Human genes 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- ODBLHEXUDAPZAU-ZAFYKAAXSA-N D-threo-isocitric acid Chemical compound OC(=O)[C@H](O)[C@@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-ZAFYKAAXSA-N 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 102100034013 Gamma-glutamyl phosphate reductase Human genes 0.000 description 1
- 108010052375 Glutamate Dehydrogenase (NADP+) Proteins 0.000 description 1
- 108010016106 Glutamate-5-semialdehyde dehydrogenase Proteins 0.000 description 1
- 102000012011 Isocitrate Dehydrogenase Human genes 0.000 description 1
- 108010075869 Isocitrate Dehydrogenase Proteins 0.000 description 1
- 108020003285 Isocitrate lyase Proteins 0.000 description 1
- ODBLHEXUDAPZAU-FONMRSAGSA-N Isocitric acid Natural products OC(=O)[C@@H](O)[C@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-FONMRSAGSA-N 0.000 description 1
- KABXUUFDPUOJMW-BYPYZUCNSA-N L-glutamic 5-semialdehyde Chemical compound OC(=O)[C@@H](N)CCC=O KABXUUFDPUOJMW-BYPYZUCNSA-N 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 102000002568 Multienzyme Complexes Human genes 0.000 description 1
- 108010093369 Multienzyme Complexes Proteins 0.000 description 1
- 101710138959 NAD-specific glutamate dehydrogenase Proteins 0.000 description 1
- XJLXINKUBYWONI-NNYOXOHSSA-O NADP(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-O 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108700023175 Phosphate acetyltransferases Proteins 0.000 description 1
- 108090000612 Proline Oxidase Proteins 0.000 description 1
- 102000004177 Proline oxidase Human genes 0.000 description 1
- 102000004518 Pyrroline-5-carboxylate reductase Human genes 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 108010042687 Pyruvate Oxidase Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000002414 glycolytic effect Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 101150034989 idhA gene Proteins 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 238000007857 nested PCR Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 101150084945 pdhA gene Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108020001898 pyrroline-5-carboxylate reductase Proteins 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229960001479 tosylchloramide sodium Drugs 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/24—Proline; Hydroxyproline; Histidine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/11—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910940707.3A CN110551672B (zh) | 2019-09-30 | 2019-09-30 | 高产反式-4-羟基-l-脯氨酸的大肠杆菌菌株及其构建方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910940707.3A CN110551672B (zh) | 2019-09-30 | 2019-09-30 | 高产反式-4-羟基-l-脯氨酸的大肠杆菌菌株及其构建方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110551672A CN110551672A (zh) | 2019-12-10 |
CN110551672B true CN110551672B (zh) | 2023-05-23 |
Family
ID=68742230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910940707.3A Active CN110551672B (zh) | 2019-09-30 | 2019-09-30 | 高产反式-4-羟基-l-脯氨酸的大肠杆菌菌株及其构建方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110551672B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115806927A (zh) * | 2022-11-29 | 2023-03-17 | 天津科技大学 | 用于生产反式-4-羟基脯氨酸的基因工程菌及其构建方法与应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7041814B1 (en) * | 1998-02-18 | 2006-05-09 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Enterobacter cloacae for diagnostics and therapeutics |
CN1839201A (zh) * | 2003-06-18 | 2006-09-27 | 吉恩勒克斯公司 | 修饰的重组痘苗病毒及其它微生物,及其应用 |
CN101115832A (zh) * | 2004-11-26 | 2008-01-30 | 协和发酵工业株式会社 | 工业上有用的微生物 |
CN107805621A (zh) * | 2017-10-27 | 2018-03-16 | 中国科学院成都生物研究所 | 一种利用大肠杆菌合成反式‑4‑羟基‑l‑脯氨酸的方法 |
WO2018074916A1 (en) * | 2016-10-18 | 2018-04-26 | Technische Universiteit Delft | Methods for increasing production of carbapenem antibiotics and derivatives in bacteria |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080009041A1 (en) * | 2004-11-26 | 2008-01-10 | Hiroshi Mizoguchi | Industrially Useful Microorganism |
-
2019
- 2019-09-30 CN CN201910940707.3A patent/CN110551672B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7041814B1 (en) * | 1998-02-18 | 2006-05-09 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Enterobacter cloacae for diagnostics and therapeutics |
CN1839201A (zh) * | 2003-06-18 | 2006-09-27 | 吉恩勒克斯公司 | 修饰的重组痘苗病毒及其它微生物,及其应用 |
CN101115832A (zh) * | 2004-11-26 | 2008-01-30 | 协和发酵工业株式会社 | 工业上有用的微生物 |
WO2018074916A1 (en) * | 2016-10-18 | 2018-04-26 | Technische Universiteit Delft | Methods for increasing production of carbapenem antibiotics and derivatives in bacteria |
CN107805621A (zh) * | 2017-10-27 | 2018-03-16 | 中国科学院成都生物研究所 | 一种利用大肠杆菌合成反式‑4‑羟基‑l‑脯氨酸的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN110551672A (zh) | 2019-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2281880B1 (en) | Mutant microorganism with high ability of producing putrescine and preparation of putrescine using same | |
CN111607623B (zh) | 一种代谢工程改造大肠杆菌制备α-酮异戊酸的方法 | |
CN110699394B (zh) | 一种生产1,5-戊二胺的生物转化法 | |
CN112143764B (zh) | 一种生物酶催化制备布瓦西坦中间体化合物的方法 | |
CN112063572B (zh) | 一种高产o-乙酰-l-高丝氨酸的重组大肠杆菌及其应用 | |
WO2022174597A1 (zh) | 一种用于l-肌氨酸生产的基因工程菌及构建方法与应用 | |
WO2016065709A1 (zh) | 利用乙酸生产丁二酸的代谢工程大肠杆菌菌株构建方法和应用 | |
CN110551672B (zh) | 高产反式-4-羟基-l-脯氨酸的大肠杆菌菌株及其构建方法 | |
KR102109763B1 (ko) | 2,3―부탄디올의 생성능이 증강된 재조합 미생물 및 이를 이용한 2,3―부탄디올의 생산 방법 | |
US20090042275A1 (en) | Novel plasmids and utilization thereof | |
CN112592875B (zh) | 一株高丝氨酸生产菌及其构建方法和应用 | |
CN114075524B (zh) | 阿魏酸生产工程菌、其建立方法及其应用 | |
CN113736719B (zh) | 一种谷氨酸棒杆菌基因工程菌及其在亚精胺生产中的应用 | |
CN116426455B (zh) | 一种重组大肠杆菌及其构建方法与其在生产3-脱氢莽草酸中的应用 | |
CN112080452A (zh) | 一种高产苯乳酸地衣芽孢杆菌基因工程菌、生产苯乳酸的方法和应用 | |
CN112725251A (zh) | 一种生产亚精胺的工程菌 | |
CN116024150A (zh) | 一种生产乙偶姻基因工程菌株及其构建方法与应用 | |
CN111748564B (zh) | 经过遗传改造的紫色杆菌素生物合成基因簇、重组表达载体、工程菌及其应用 | |
CN115011614A (zh) | Pa22基因作为负调控因子在提高成团泛菌合成草欧菌素A产量中的应用 | |
WO2020107783A1 (zh) | 一种多酶耦合制备(s)-1,2,3,4-四氢异喹啉-3-甲酸的方法 | |
CN116064352A (zh) | 高产1,3-丙二醇的克雷伯氏工程菌构建方法及应用 | |
KR20150035657A (ko) | 2,3-부탄디올의 생성능이 증강된 재조합 미생물 및 이를 이용한 2,3-부탄디올의 생산 방법 | |
CN115716868B (zh) | 转录因子MrPigB突变体及其应用 | |
CN117004547B (zh) | 一种以葡萄糖为底物从头合成顺,顺-粘康酸的基因工程菌及其应用 | |
CN118064472A (zh) | 一种利用乙酸合成苯酚的重组大肠杆菌的构建方法及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231220 Address after: 610000 150 hele 2nd Street, high tech Zone, Chengdu, Sichuan Province Patentee after: Chengdu Yinyuan Synthetic Biotechnology Co.,Ltd. Address before: 610041 No. four, South Renmin Road, Sichuan, Chengdu province 9 Patentee before: CHENGDU INSTITUTE OF BIOLOGY, CHINESE ACADEMY OF SCIENCES |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240226 Address after: Room 2603, 26th Floor, Unit 1, Building 1, No. 555, Middle Section of Yizhou Avenue, High tech Zone, Chengdu City, Sichuan Province, 610000 Patentee after: Yuanchuang Botai (Chengdu) Biotechnology Co.,Ltd. Country or region after: China Address before: 610000 150 hele 2nd Street, high tech Zone, Chengdu, Sichuan Province Patentee before: Chengdu Yinyuan Synthetic Biotechnology Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |